F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,549 | 18,526 | 4,901 | 14,724 | 23,649 |
| Marketable Securities | N/A | N/A | N/A | 32,914 | 26,906 |
| Receivables | 2,311 | 3,563 | 10,532 | N/A | N/A |
| TOTAL | $84,739 | $26,065 | $19,021 | $49,287 | $51,135 |
| Non-Current Assets | |||||
| PPE Net | 887 | 789 | 1,425 | 2,319 | 687 |
| Investments And Advances | 0 | 0 | 0 | 16,804 | 0 |
| Intangibles | 14,898 | 14,926 | 4,320 | 0 | 0 |
| Other Non-Current Assets | 22,497 | 21,829 | 13,712 | 401 | 519 |
| TOTAL | $38,282 | $37,544 | $19,457 | $19,524 | $1,206 |
| Total Assets | $123,021 | $63,609 | $38,478 | $68,811 | $52,341 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 14,906 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,081 | 4,597 | 5,056 | 1,880 | 1,700 |
| Accrued Expenses | 6,241 | 9,461 | 8,876 | 2,367 | 2,734 |
| Other current liabilities | 1,907 | 2,080 | N/A | N/A | N/A |
| TOTAL | $12,135 | $16,977 | $29,890 | $4,247 | $4,434 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,605 | N/A | N/A | N/A | N/A |
| Deferred Revenues | N/A | 300 | 442 | N/A | N/A |
| Other Non-Current Liabilities | 1,694 | 440 | 0 | 8,704 | 13,159 |
| TOTAL | $14,029 | $3,638 | $52 | $8,704 | $13,159 |
| Total Liabilities | $26,164 | $20,615 | $29,942 | $12,951 | $17,593 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,065 | 9,100 | 4,128 | 4,109 | 3,241 |
| Common Shares | 2 | 1 | 1 | 2 | 1 |
| Retained earnings | -78,451 | -47,168 | -21,549 | -102,068 | -79,214 |
| Other shareholders' equity | -1,502 | -1,077 | -1,634 | -5 | -23 |
| TOTAL | $96,857 | $42,994 | $8,536 | $55,860 | $34,748 |
| Total Liabilities And Equity | $123,021 | $63,609 | $38,478 | $68,811 | $52,341 |